Monopar Therapeutics Earnings Per Share, Basic in USD/shares from Q2 2022 to Q3 2025

Taxonomy & unit
us-gaap: USD/shares
Description
The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.
Summary
Monopar Therapeutics quarterly/annual Earnings Per Share, Basic history and growth rate from Q2 2022 to Q3 2025.
  • Monopar Therapeutics Earnings Per Share, Basic for the quarter ending September 30, 2025 was -0.48 USD/shares, a 29.7% decline year-over-year.
  • Monopar Therapeutics Earnings Per Share, Basic for the twelve months ending September 30, 2025 was -3 USD/shares, a 17.2% decline year-over-year.
  • Monopar Therapeutics annual Earnings Per Share, Basic for 2024 was -4.11 USD/shares, a 35.2% decline from 2023.
  • Monopar Therapeutics annual Earnings Per Share, Basic for 2023 was -3.04 USD/shares, a 266% decline from 2022.
Earnings Per Share, Basic, Trailing 12 Months (USD/shares)
Earnings Per Share, Basic, Quarterly (USD/shares)
Earnings Per Share, Basic, YoY Quarterly Growth (%)
Earnings Per Share, Basic, Annual (USD/shares)
Earnings Per Share, Basic, YoY Annual Growth (%)

Monopar Therapeutics Quarterly Earnings Per Share, Basic (USD/shares)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2025 -$3 $0 $0 -29.7% Jul 1, 2025 Sep 30, 2025 10-Q 2025-11-13
Q2 2025 -$3 $0 +$0.14 +28.6% Apr 1, 2025 Jun 30, 2025 10-Q 2025-08-12
Q1 2025 -$3 $0 +$0.13 +25.5% Jan 1, 2025 Mar 31, 2025 10-Q 2025-05-13
Q4 2024 -$4 -$3 -$1 -37% Oct 1, 2024 Dec 31, 2024 10-K 2025-03-31
Q3 2024 -$3 $0 +$0.32 +46.4% Jul 1, 2024 Sep 30, 2024 10-Q 2025-11-13
Q2 2024 -$3 $0 $0 -206% Apr 1, 2024 Jun 30, 2024 10-Q 2025-08-12
Q1 2024 -$3 -$1 $0 -168% Jan 1, 2024 Mar 31, 2024 10-Q 2025-05-13
Q4 2023 -$3 -$2 Oct 1, 2023 Dec 31, 2023 10-K 2025-03-31
Q3 2023 -$1 -$1 -263% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-08
Q2 2023 $0 +$0.06 +27.3% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-09
Q1 2023 $0 Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-09
Q3 2022 $0 Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-09
Q2 2022 $0 Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-10

Monopar Therapeutics Annual Earnings Per Share, Basic (USD/shares)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 -$4 -$1 -35.2% Jan 1, 2024 Dec 31, 2024 10-K 2025-03-31
2023 -$3 -$2 -266% Jan 1, 2023 Dec 31, 2023 10-K 2025-03-31
2022 -$1 Jan 1, 2022 Dec 31, 2022 10-K 2024-03-28
* An asterisk sign (*) next to the value indicates that the value is likely invalid.